Featuring perspectives from Dr Anne Chiang, Ms Elizabeth Krueger, Ms Beth Sandy and Dr Erin Schenk, including the following topics:

• Introduction: Overview of Bispecific Antibodies (0:00)
• Biology of Small-Cell Lung Cancer (SCLC) and Review of Its Initial Management (13:37)
• Case: 63-year-old man — Ms Krueger (23:36)
• Current Role of Tarlatamab in Therapy for SCLC (33:40)
• Case: 70-year-old woman — Ms Sandy (43:41)
• Future Directions in the Management of SCLC (50:45)
• Case: 81-year-old man — Ms Krueger (1:01:24)
• Unique Considerations in SCLC Management (1:09:29)
• Case: 67-year-old woman — Ms Sandy (1:22:53)

NCPD information and select publications